A la recherche de modulateurs de l'activité transcriptionnelle des récepteurs nucléaires

Medecine/Sciences

Volumn 12, Issue 2, 1996, Pages 229-233

  Cavaillès, Vincent ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4243121124     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/720     Document Type: Article

References (17)

1. Parker MG. Steroid and related receptors. Curr Opin Cell Biol 1993 ; 5:499-504.
2. Lavau C, Jansen J, Weis K, Lamond A, Dejean A. Leucémie aiguē promyélocytairc et acide rétinoīque : le paradoxe. médecine/ sciences 1994; 10 : 817-24.
3. Danielian PS, White R, Lees JA, Parker MG. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992; 11: 1025-33.
4. Pierrat B, Heery DM, Chambon P, Losson R. A highly conserved region in the hormone binding domain of the human estrogen receptor functions as an efficient transactivation domain in yeast. Gene 1994; 143: 193-200.
5. Tanese N, Tjian R. Coactivators and TAFs: a new class of eukaryotic transcription factors that connect activators to the basal machinery. Cold Spring Harbor Symp Quant Biol 1993; 58: 179-85.
6. Ing NH, Beekman JM, Tsai SY, Tsai MJ, O'Malley BW. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J Biol Chem 1992; 267: 17617-23.
7. Blanco JCG, Wang I, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, Haussler MR, Ozato K. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 1995; 92: 1535-9.
8. Tasset D, Tora L, Fromental C, Scheer E, Chambon P. Distinct classes of transcriptional activating domains function by different mechanisms. Cell 1990; 62: 1177-87
9. Jacq X, Brou C, Lutz Y, Davidson I. Chambon P, Tora L. Human TAFII30 is present in a distinct TFIID complex and is required for transcripaonal activation by the estrogen receptor. Cell 1994; 79: 107-17.
10. Plessis A, Camonis JH. Le système double hybride, mode d'emploi. médicine/ sciences 1994; 10: R1-R9.
11. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD. Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 1995; 374: 91-4.
12. Cavaillès V, Dauvois S, Danielian PS. Parker MG. Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 1994; 91: 10009-13.
13. Halachmi S, Marden E, Martin G. MacKay H, Abbondanza C, Brown M. Estrogen receptor-associated proteins - possible mediators of hormone-induced transcription. Science 1994; 264: 1455-8.
14. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. Nuclear factor RIPI40 modulates transcriptional activation by the estrogen receptor. EMBO J 1995; 14: 3741-51.
15. Le Douarin B, Zechel C, Gamier J, Lutz Y, Tora L, Pierrat B, Heery D, Gronemeyer H, Chambon P, Losson R. The N-terminal part of TIF1, a putative mediator of the ligand dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995; 14: 2020-33
16. Winston F, Carlson M. Yeast SNF/SWI transcriptional activators and the SPT/SIN connection. Trends Genet 1992; 8; 387-91.
17. Baniahmad C, Nawaz Z, Baniahmad A, Gieeson MAG, Tsai M, O'Malley BW. Enhancement of human estrogen receptor activitv by SPT6: a potential coactivator. Mol Endocrinol 1995; 9: 34-43.